GlobeNewswire Inc.··NaRelmada Therapeutics to Unveil Q4 2025 Results Amid $160M Funding Boost
Relmada Therapeutics to report Q4 2025 results March 19, 2026, following $160M oversubscribed fundraise and Leerink Partners conference presentation.
RLMDclinical-stage biotechprivate placement